ATE276276T1 - Rekombinanter anti-hiv antikörper und seine herstellung - Google Patents

Rekombinanter anti-hiv antikörper und seine herstellung

Info

Publication number
ATE276276T1
ATE276276T1 AT93901547T AT93901547T ATE276276T1 AT E276276 T1 ATE276276 T1 AT E276276T1 AT 93901547 T AT93901547 T AT 93901547T AT 93901547 T AT93901547 T AT 93901547T AT E276276 T1 ATE276276 T1 AT E276276T1
Authority
AT
Austria
Prior art keywords
antibody
hiv
codes
activity
human
Prior art date
Application number
AT93901547T
Other languages
English (en)
Inventor
Hiroaki Maeda
Kazuhiko Kimachi
Yasuyuki Eda
Kouichi Shiosaki
Kiyoshi Osatomi
Sachio Tokiyoshi
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE276276T1 publication Critical patent/ATE276276T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93901547T 1993-01-14 1993-01-14 Rekombinanter anti-hiv antikörper und seine herstellung ATE276276T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002153165A CA2153165C (en) 1993-01-14 1993-01-14 Recombinant anti-hiv antibody and process for preparing the same
PCT/JP1993/000039 WO1994015969A1 (fr) 1993-01-14 1993-01-14 Anticorps anti-vih recombine et sa preparation

Publications (1)

Publication Number Publication Date
ATE276276T1 true ATE276276T1 (de) 2004-10-15

Family

ID=25678063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93901547T ATE276276T1 (de) 1993-01-14 1993-01-14 Rekombinanter anti-hiv antikörper und seine herstellung

Country Status (10)

Country Link
US (1) US5773247A (de)
EP (1) EP0678523B1 (de)
AT (1) ATE276276T1 (de)
AU (1) AU671608B2 (de)
CA (1) CA2153165C (de)
DE (1) DE69333627T2 (de)
DK (1) DK0678523T3 (de)
ES (1) ES2229206T3 (de)
PT (1) PT678523E (de)
WO (1) WO1994015969A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399067B1 (en) * 2000-04-28 2002-06-04 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US7090843B1 (en) 2000-11-28 2006-08-15 Seattle Genetics, Inc. Recombinant anti-CD30 antibodies and uses thereof
US7148038B2 (en) * 2001-10-16 2006-12-12 Raven Biotechnologies, Inc. Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
US7405061B2 (en) * 2002-11-13 2008-07-29 Raven Biotechnologies, Inc. Antigen PIPA and antibodies that bind thereto
JP2008535783A (ja) 2005-02-15 2008-09-04 サイモン・エル・エル・シー Ｈｉｖ−１の増殖を弱めるための方法および組成物
WO2010129917A2 (en) * 2009-05-08 2010-11-11 Vaccinex, Inc. Anti-cd100 antibodies and methods for using the same
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
CN102212133B (zh) * 2011-03-30 2013-01-16 中国医学科学院病原生物学研究所 人源HIV抗体的Fab片段及其编码基因与应用
CN102190726B (zh) * 2011-03-30 2013-03-27 中国医学科学院病原生物学研究所 一种人源HIV抗体的Fab片段及其编码基因与应用
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) * 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JP2646007B2 (ja) * 1988-01-30 1997-08-25 財団法人 化学及血清療法研究所 抗ｈｉｖ抗体可変領域をコードする遺伝子断片およびこれらを用いて発現された抗ｈｉｖキメラ抗体ならびにその製法
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体

Also Published As

Publication number Publication date
EP0678523A4 (de) 1998-08-05
CA2153165C (en) 2003-05-06
DK0678523T3 (da) 2005-01-10
ES2229206T3 (es) 2005-04-16
EP0678523B1 (de) 2004-09-15
WO1994015969A1 (fr) 1994-07-21
US5773247A (en) 1998-06-30
DE69333627D1 (de) 2004-10-21
EP0678523A1 (de) 1995-10-25
DE69333627T2 (de) 2005-09-22
AU671608B2 (en) 1996-09-05
CA2153165A1 (en) 1994-07-21
PT678523E (pt) 2004-12-31
AU3267193A (en) 1994-08-15

Similar Documents

Publication Publication Date Title
ATE276276T1 (de) Rekombinanter anti-hiv antikörper und seine herstellung
EA200601715A1 (ru) Получение гуманизированных антител в [организме] трансгенных животных
DK0380068T3 (da) Ekspressionssystem til fremstilling af kimære monoklonale antistoffer
EP0690132A4 (de) Monoklonaler anti-hiv antikörper
LTC0918797I2 (lt) Humanizuotas imunoglobulinas reaguojantis su alfa4beta7 integrinu
DE69330031D1 (de) Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment
ATE102993T1 (de) Virale expressionsinhibitoren.
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
GB8607679D0 (en) Recombinant dna product
SE8601325D0 (sv) Sett att producera ett immunglobulinbindande protein samt medel for detta
PT592836E (pt) Adn do local de integracao do virus adeno-associado humano e suas utilizacoes
JP2004528803A5 (de)
CA2022959C (en) Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin
MX9301858A (es) Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
ATE119200T1 (de) Erhöhte produktion von proteinen in bakterien durch verwendung einer neuen ribosombindungsstelle.
GR3015892T3 (en) Virus resistant plants having a viral coat protein.
HUT63650A (en) Process for the modulation of gene expression by changing the secondary structure of rna
ATE337404T1 (de) Zur verleihung viraler resistenz an pflanzen geeignetes polyribozym und dieses polyribozym produzierende resistente pflanzen
EP0061740A3 (en) Process for the production of a hybrid dna containing the complementary hepatitis a virus genome, this hybrid dna and plasmid vector containing it, virus-specific proteins expressed by this hybrid dna, vaccines containing and produced from these proteins
EP0603672A3 (de) Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung.
CN120518752A (zh) 同时针对寨卡病毒和乙脑病毒的抗体或抗原结合片段、核酸、重组载体与应用
CN1318565A (zh) 人源抗甲肝病毒中和性基因工程全抗体

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0678523

Country of ref document: EP

REN Ceased due to non-payment of the annual fee